CME Group is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $262.54 – an increase of 0.26% over the previous week. CME Group employs 3,760 staff and has a trailing 12-month revenue of around $6.1 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $262.54 |
|---|---|
| 52-week range | $183.31 - $267.91 |
| 50-day moving average | $248.70 |
| 200-day moving average | $224.91 |
| Wall St. target price | $257.65 |
| PE ratio | 27.1449 |
| Dividend yield | $4.6 (4.12%) |
| Earnings per share (TTM) | $9.66 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $262.24 from 2025-04-01
| 1 week (2025-03-27) | 0.15% |
|---|---|
| 1 month (2025-03-03) | 2.09% |
| 3 months (2025-01-03) | 12.79% |
| 6 months (2024-10-03) | 16.93% |
| 1 year (2024-04-03) | 23.68% |
|---|---|
| 2 years (2023-04-03) | 51.05% |
| 3 years (2022-04-01) | 25.77% |
| 5 years (2020-04-02) | 90.73% |
Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, CME Group shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.2545. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 billion.
The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $6.1 billion |
|---|---|
| Operating margin TTM | 62.54% |
| Gross profit TTM | $6.1 billion |
| Return on assets TTM | 1.84% |
| Return on equity TTM | 13.25% |
| Profit margin | 57.61% |
| Book value | $73.66 |
| Market Capitalization | $94.5 billion |
TTM: trailing 12 months
Dividend payout ratio: 91.13% of net profits
Recently CME Group has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $4.6 per share.
CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
CME Group's most recent dividend payout was on 25 March 2025. The latest dividend was paid out to all shareholders who bought their shares by 6 March 2025 (the "ex-dividend date").
CME Group's shares were split on a 5:1 basis on 22 July 2012 . So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.
Over the last 12 months, CME Group's shares have ranged in value from as little as $183.31 up to $267.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.547. This would suggest that CME Group's shares are less volatile than average (for this exchange).
CME Group Inc. , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Looking to invest in AI stocks? Here are some of the best artificial intelligence stocks available, along with tips to better understand AI investments.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.